compounders sue fda over ending semaglutide shortage Minus one of its GLP-1 cash cows, compounding group sues Drug compounders sue over weight
Description
Although in recent years Ozempic has been often prescribed off-label for weight loss, it is not currently approved for this indication
In the biggest phase 3 study that looked at orforglipron stacked up against a placebo in patients with diabetes , weight reduction on the largest dose (36mg) was 7.9% over 40 weeks
Carbohydrate fermentation decreases hepatic glucose output in healthy subjects
SOURCE: American College of Chest Physicians, news release, Oct
And 350 million people there live with obesity
DOI: 10.1007/s13300-020-00979-8 6
